Organization · Venture Capital
Galen Partners
Galen Partners is a healthcare growth equity firm based in Stamford, Connecticut, focusing on investments in established healthcare companies. Founded in 1990, it targets proven businesses that improve health outcomes and lower costs.
Overview
What Galen Partners does
What Galen Partners is
Galen Partners is a healthcare growth equity firm based in Stamford, Connecticut, focusing on investments in established healthcare companies. Founded in 1990, it targets proven businesses that improve health outcomes and lower costs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1990
- Approximate age
- About 36 years
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find Galen Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Galen Partners as a funder
Investment thesis
Galen Partners believes healthcare is undergoing a generational transformation towards companies that create measurable healthcare value. Their investments must improve health outcomes, lower costs, or achieve both.
Focus narrative
Galen Partners targets growth equity opportunities in the healthcare sector, specifically looking for established companies that demonstrate the potential to improve health outcomes and lower costs. The firm does not invest in seed-stage or early venture companies, instead focusing on scaling proven businesses that are well-positioned to benefit from significant changes in healthcare.
Value beyond capital
Galen Partners adds value to its portfolio companies by leveraging its extensive experience in healthcare investing, providing strategic guidance, and facilitating connections within the industry to help companies scale effectively and navigate the complexities of the healthcare landscape.
Terms and economics
- Typical check
- $10,000,000–$30,000,000
Focus and fit
- Stages
- Growth Equity
- Sectors
- Healthcare · Medical Devices · Diagnostics
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 80
- Recorded notable exits
- MedAssets, Pyxis, MiniMed, Ocular Sciences, Medicode, and Dow Pharmaceutical Sciences, plus 2 more
Portfolio context
Galen Partners has invested in over 80 companies, including notable names such as MedAssets, a leader in healthcare technology and services; Pyxis, known for medication dispensing automation; MiniMed, a diabetes medical technology company acquired by Medtronic; and Ocular Sciences, a vision care company acquired by CooperVision.
Common questions
What to know about Galen Partners
Upseed classifies Galen Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.